2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease | Synapse
April 26, 2026Journal of the American College of Cardiology307 citationsOpen Access
2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease
This consensus aims to evaluate novel therapies for cardiovascular risk reduction in patients with type 2 diabetes and existing cardiovascular disease.
Consensus statement was developed by leading experts in cardiovascular disease and diabetes management.
Reviewed recent clinical studies related to cardiovascular risk in patients with type 2 diabetes.
Identified key strategies and treatments for optimal patient care.
Confirmed that certain therapies significantly lower cardiovascular risk in type 2 diabetes patients.
Endorsed the use of specific medications that demonstrate cardiovascular benefits.
Highlighted the importance of individualized treatment plans based on patient profiles.
Abstract
No abstract was published with this document — society guidelines, consensus pathways, and scientific statements are typically released without one. See the Key Points and the linked PDF for the full content.